The HemoCue Glucose Systems are based on a glucose dehydrogenase method and consists of a small, dedicated analyzer and a unique disposable microcuvette.The systems combine the precision and accuracy of a central laboratory with the speed and convenience of obtaining results at the point-of-care. With just a fraction of a drop of blood and three simple steps, the HemoCue Glucose Systems will produce immediate, accurate results for screening, diagnosing or monitoring diabetes, as well as monitoring neonatal blood glucose levels.

• Higher reimbursement than home use glucose meters
• Immediate, accurate results covering the whole measurement range
• Glucose 201 Analyzer: 0-444 mg/dL (0-24.6 mmol/L)
• Only 5 µL of capillary, venous, or arterial blood is needed
• Technique-independent results
• No inherent limitations related to hematocrit or known drug interferences
• No calibration or microcuvette batch-to-batch variations
• The HemoCue Gluco